Search clinical trials for: Antifungal Agents

Total 186844 results

Bayer

Completed

Study to Determine Skin Irritation and/or Sensitization Potential of an Antifungal Cream Containing Trolamine (Repeated Insult Patch Test)

Hypersensitivity

United States
Bayer

Completed

Study to Learn More About the Potential of Antifungal Cream V61-044 Containing Trolamine to Cause Irritant Reaction of the Skin to Ultra Violet Light in Healthy Human Subjects

Dermatitis, Phototoxic

United States
Astellas Pharma China, Inc.

Terminated

Post Marketing Study to Evaluate the Safety and Efficacy of Micafungin Against Fungal Infections Caused by Candida Spp or Aspergillus Spp

Candidiasis | Aspergillosis

China
Medical University of Vienna

Completed

Pharmacokinetics of Micafungin During Continuous Venovenous Hemofiltration (Mica-HDF)

Candida Sepsis

Austria
University of Medicine and Dentistry of New Jersey

Withdrawn

Chemoprevention of Cancer in the Lower Female Genital Tract: The Antineoplastic Activity of the Fungicide Ciclopirox.

Vulvar Cancer

United States
Scynexis, Inc.

Completed

Ibrexafungerp for the Treatment of Complicated Vulvovaginal Candidiasis

Vulvovaginal Candidiasis

United States
Scynexis, Inc.

Completed

ADME Study of [14^C]-Ibrexafungerp in Healthy Male Subjects

Fungal Disease

United Kingdom
Pfizer

Completed

Anidulafungin In Treatment Of Candidemia In Asian Subjects

Candidemia

Taiwan, India, Thailand, Philippines
Medical University of Vienna

Unknown

Anidulafungin During Continuous Venovenous Hemofiltration (CVVHF)

Acute Renal Failure | Infection

Austria
Astellas Pharma China, Inc.

Terminated

A Study to Evaluate the Efficacy and Safety of Micafungin Against Invasive Candidiasis or Candidemia

Candidemia | Candidiasis

China
Pfizer
Vicuron Pharmaceuticals

Completed

Safety, Tolerance and Pharmacokinetics of Anidulafungin in Immunocompromised Children Ages 2-17

Neutropenia

United States
Pfizer

Completed

Patterns of Real-World Isavuconazole Use - a Study of Patients With Mucormycosis or Invasive Aspergillosis (PRISMA)

Mucormycosis | Invasive Aspergillosis

Spain, Germany, France, United Kingdom, Italy
Yung Shin Pharm. Ind. Co., Ltd.

Completed

Evaluate Bioequivalence of Micafungin (50mg/Vial)

Invasive Candidiasis

Taiwan
F2G Biotech GmbH
Covance

Completed

A Biopharmaceutics Study to Assess the Pharmacokinetics of Single Oral and IV Doses of Olorofim

Healthy

United Kingdom
F2G Biotech GmbH
PRA Health Sciences

Completed

Absorption, Metabolism and Excretion of 14C-olorofim in Man (hAME)

Invasive Fungal Infections

Netherlands
Astellas Pharma Global Development, Inc.
IRCCS, Ospedale Pediatrico Bambino Gesu

Completed

Determination of Levels of Micafungin in Neonates Suffering From Systemic Candidiasis and/or Candida Meningitis

Candidiasis, Systemic | Candida Meningitis

Italy
Texas Tech University Health Sciences Center
University of Texas Southwestern Medical Center; National Center for Research...

Completed

Effect of Weight and/or Obesity on Anidulafungin Drug Concentrations

Obesity | Mycoses

United States
Astellas Pharma China, Inc.

Completed

A Retrospective Study Evaluating the Efficacy and Safety of Micafungin Sodium in the Treatment of Invasive Fungal Infections

Invasive Fungal Infections

China
National Cancer Institute (NCI)

Completed

Anidulafungin in Treating Immunocompromised Children With Neutropenia

Unspecified Childhood Solid Tumor, Protocol Specific | Neutropenia | Infection

United States
Elisabethinen Hospital
Pfizer

Terminated

Anidulafungin in Patients With Hematologic Malignancies (ECALTA)

Hematologic Malignancies

Austria
University of Texas Southwestern Medical Center
Astellas Pharma US, Inc.

Completed

Drug Concentration Analysis of Micafungin in Overweight, Obese, and Extremely Obese Volunteers (Micafungin)

Obesity | Nutrition Disorders | Overweight

United States
University Hospital, Limoges

Completed

Pharmacokinetics of Micafungin in Patients of Intensive Care Units (MI-K)

Invasive Candidiasis

France
F2G Biotech GmbH
Covance

Completed

Assessment of Varying Oral Dosing Regimens for F901318 in Healthy Subjects

Invasive Aspergillosis

United Kingdom
Astellas Pharma Inc

Completed

Study of Mycamine® in Children With Fungal Infections to Evaluate Safety and Blood Levels of the Drug

Candidemia | Invasive Candidiasis | Esophageal Candidiasis | Oropharyngeal Candidiasis

United States, South Africa
Children's Hospital Medical Center, Cincinnati
Astellas Pharma Inc

Terminated

A Pharmacokinetic Study of Pediatric Micafungin Prophylaxis (Micafungin)

Cancer | Immunocompromised | Bone Marrow Transplant

United States
National Cancer Institute (NCI)

Completed

Anidulafungin Versus Fluconazole in the Treatment of Candidemia

Candidiasis | Candida

United States
Universidade Federal do Rio de Janeiro

Completed

Negative Beta Glucan in ICU Patients

Candidemia

Brazil
Astellas Pharma China, Inc.

Terminated

Post Marketing Study to Evaluate the Efficacy and Safety of Micafungin Treatment on Invasive Aspergillosis

Invasive Aspergillosis

China
F2G Biotech GmbH
Quotient Clinical

Withdrawn

Pharmacokinetics of IV Formulation

Invasive Aspergillosis
Nantes University Hospital

Completed

Antifungal Prophylaxis With Micafungin After Cord Blood Allogeneic Stem Cell Transplantation (MycaCOORD) (MycaCOORD)

Invasive Fungal Infection

France
Michael Cohen-Wolkowiez

Completed

Anidulafungin PK in Infants and Toddlers

Invasive Fungal Infections

United States
Children's Hospital Medical Center, Cincinnati
Astellas Pharma Inc

Completed

Alternate Day Micafungin: A PK Study in Pediatric Patients

Fungal Infection

United States
Rady Children's Hospital, San Diego

Completed

Topical Penlac Nail Lacquer for Onychomycosis in Children

Onychomycosis

United States
National Cancer Institute (NCI)

Completed

Phase I Study of the Safety, Tolerance, and Pharmacokinetics of FK463 in Immunocompromised Children With Fever and Neutropenia

Mycoses | Neutropenia | Fever

United States
Pfizer

Recruiting

Cresemba® in Treating Chinese Patients With IFD Caused by Aspergillus Species or Other Filamentous Fungi

Invasive Fungal Disease

China
Astellas Pharma Inc

Completed

Study of FK463 in the Treatment of Candidemia or Invasive Candidiasis

Candidiasis

United Kingdom, Austria, France, Germany, Italy, Poland, Spain, Sweden
Niuvanniemi Hospital
Karolinska Institutet

Withdrawn

Sodium Benzoate for Treatment of Attenuated/Transient Psychosis. A Randomized Placebo-controlled Trial. (AttenPsyc)

Attenuated or Transient Psychosis

Finland
Asan Medical Center
Astellas Pharma Korea, Inc.

Unknown

Micafungin Prevention Study for Fungal Disease in Child Receiving Allogenic Hematopoietic Stem Cell Transplantation

Neutropenia | Hematopoietic Stem Cell Transplantation | Invasive Fungal Disease

Korea, Republic of
Hartford Hospital
Melinta Therapeutics, LLC

Not yet recruiting

Rezafungin PK in Patients on ECMO

Sepsis

United States
Scynexis, Inc.

Completed

Study to Evaluate the Efficacy and Safety of Ibrexafungerp in Patients With Fungal Diseases That Are Refractory to or Intolerant of Standard Antifungal Treatment (FURI)

Coccidioidomycosis | Invasive Pulmonary Aspergillosis | Allergic Bronchopulmonary Aspergillosis | Histoplasmosis | Chronic Pulmonary Aspergillosis | Blastomycosis | Invasive Candidiasis | Recurrent Vulvovaginal Candidiasis | Mucocutaneous Candidiasis | Other Emerging Fungi

United States, Spain, United Kingdom, Austria, Pakistan, Germany, Netherlands, South Africa
Scynexis, Inc.

Completed

Open-Label Study to Evaluate the Efficacy and Safety of Oral Ibrexafungerp (SCY-078) in Patients With Candidiasis Caused by Candida Auris (CARES) (CARES)

Candidemia | Candidiasis, Invasive

Pakistan, India, United States, South Africa
F2G Biotech GmbH

Completed

A Phase I Study to Assess the Pharmacokinetics of Olorofim in Subjects With Hepatic Impairment

Hepatic Impairment

United States
Memorial Sloan Kettering Cancer Center
Astellas Pharma US, Inc.

Completed

Fungal Prophylaxis With Isavuconazole for Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant (HCT)

Hematologic Malignancy | Myeloproliferative Disorder

United States
Seoul National University Hospital
Astellas Pharma Inc

Completed

Micafungin Prophylaxis During 1st Induction Chemotherapy for De Novo Acute Leukemia

Acute Leukemia
Radboud University Medical Center

Completed

Pharmacokinetics of Micafungin in Patients Intensive Care Unit (MIMIC)

Invasive Fungal Infection

Netherlands
Curatek Pharmaceuticals, LLC

Completed

Multi-Center Study of New Medications to Treat Vaginal Infections (SMART GIVES)

Vaginal Infection

United States
Astellas Pharma S.A.S.

Completed

Use of Micafungin (Mycamine®) as Antifungal Prophylaxis in Haematology and Onco-haematology (OLYMPE)

Antifungal Prophylaxis | Haemopathy

France
F2G Biotech GmbH
Iqvia Pty Ltd

Recruiting

Evaluate F901318 Treatment of Invasive Fungal Infections in Patients Lacking Treatment Options (FORMULA-OLS)

Invasive Fungal Infections

United States, Netherlands, Israel, Spain, Korea, Republic of, Belgium, Australia, Germany, France, Brazil, Poland, Egypt, Russian Federation, Thailand, Turkey, United Kingdom, Vietnam
University of Melbourne

Active, not recruiting

The PEBBLES Study - Testing a Strategy for Preventing Eczema and Food Allergy in High Risk Infants (PEBBLES)

Asthma | Eczema | Allergy;Food

Australia
Primus Pharmaceuticals

Terminated

EpiCeram for Skin Protection in Healthcare Workers Using Personal Protective Equipment

Irritant Contact Dermatitis

United States

Search clinical trials for: Antifungal Agents

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Panama

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations